Researchers discover cause of common cold

3 November 2008

Scientists from the Canadian University of Calgary have confirmed that the body's own immune system causes cold symptoms, not the rhinovirus itself, according to research published in the American Journal of Respiratory and Critical Care Medicine.

The study of 35 volunteers also found that a recently-discovered antiviral protein called viperin plays a role in the body's defense against rhinovirus. It was conducted using gene chip technology, performed by scientists at US conglomerate Proctor & Gamble. With this technology, researchers could see how every gene in the human genome responds to a stimulus, in this case a cold virus.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight